Market Analysts see BioVie Inc. [BIVI] gaining to $7. Time to buy?

BioVie Inc. [NASDAQ: BIVI] price plunged by -39.36 percent to reach at -$3.94. The company report on December 13, 2022 that In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Cuong Do, President & CEO BioVie Inc.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with BioVie.

Toni had the pleasure of recently conducting the Interview with Cuong Do, President & CEO BioVie Inc. (NASDAQ:BIVI). Toni diligently focused on questions she thought would be on the minds of most current and potential future shareholders. See interview highlights below.

A sum of 4922784 shares traded at recent session while its average daily volume was at 893.37K shares. BioVie Inc. shares reached a high of $9.795 and dropped to a low of $6.05 until finishing in the latest session at $6.07.

The one-year BIVI stock forecast points to a potential upside of 37.74. The average equity rating for BIVI stock is currently 1.70, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on BioVie Inc. [BIVI]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIVI shares is $9.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIVI stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cantor Fitzgerald have made an estimate for BioVie Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 22, 2022. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on January 15, 2021, representing the official price target for BioVie Inc. stock.

The Average True Range (ATR) for BioVie Inc. is set at 2.06 The Price to Book ratio for the last quarter was 27.59, with the Price to Cash per share for the same quarter was set at 0.73.

BIVI Stock Performance Analysis:

BioVie Inc. [BIVI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -35.90. With this latest performance, BIVI shares gained by 7.05% in over the last four-week period, additionally plugging by 261.31% over the last 6 months – not to mention a rise of 28.06% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIVI stock in for the last two-week period is set at 45.26, with the RSI for the last a single of trading hit 40.32, and the three-weeks RSI is set at 48.08 for BioVie Inc. [BIVI]. The present Moving Average for the last 50 days of trading for this stock 5.58, while it was recorded at 10.90 for the last single week of trading, and 3.50 for the last 200 days.

Insight into BioVie Inc. Fundamentals:

Return on Equity for this stock declined to -598.18, with Return on Assets sitting at -199.41.

BioVie Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.30 and a Current Ratio set at 5.30.

BioVie Inc. [BIVI] Insider Position Details

There are presently around $3 million, or 2.10% of BIVI stock, in the hands of institutional investors. The top three institutional holders of BIVI stocks are: SWISSPARTNERS LTD. with ownership of 161,000, which is approximately 0% of the company’s market cap and around 76.95% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 98,048 shares of the stock with an approximate value of $0.59 million in BIVI stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.24 million in BIVI stock with ownership of nearly 0% of the company’s market capitalization.

Positions in BioVie Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 10 institutional holders increased their position in BioVie Inc. [NASDAQ:BIVI] by around 77,539 shares. Additionally, 5 investors decreased positions by around 697,627 shares, while 4 investors held positions by with 295,129 shares. The mentioned changes placed institutional holdings at 480,037 shares, according to the latest SEC report filing. BIVI stock had 3 new institutional investments in for a total of 64,251 shares, while 2 institutional investors sold positions of 38,339 shares during the same period.


Please enter your comment!
Please enter your name here